Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities    
Net income (loss) $ 16,125 $ 19,653
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 7,436 6,058
Equity-based compensation 5,225 5,553
Equity method investments 5,572 (6,938)
Non-cash gain on securitization (16,009) (11,061)
Gain on sale of receivables and investments 0 (1,655)
Changes in receivables held-for-sale 3,143 0
Changes in accounts payable and accrued expenses (766) 2,168
Other (6,207) (129)
Net cash provided by (used in) operating activities 14,519 13,649
Cash flows from investing activities    
Equity method investments (347) (214,537)
Equity method distributions received 56,353 33,772
Purchases of receivables (3,466) (80,921)
Principal collections from receivables 16,912 55,513
Proceeds from sales of receivables 0 51,389
Purchases of real estate (15,842) (118,963)
Purchases of investments (6,384) (10,991)
Principal collections from investments 682 1,225
Funding of escrow accounts (21,518) 0
Withdrawal from escrow accounts 14,660 0
Other (728) (5,285)
Net cash provided by (used in) investing activities 40,322 (288,798)
Cash flows from financing activities    
Proceeds from credit facilities 32,938 277,612
Principal payments on credit facilities 0 (168,801)
Proceeds from issuance of non-recourse debt 46,673 258,189
Principal payments on non-recourse debt (62,067) (27,704)
Payments on deferred funding obligations (57,039) (73,927)
Net proceeds of common stock issuances 15,332 98,399
Payments of dividends and distributions (35,277) (33,020)
Other (3,447) (9,167)
Net cash provided by (used in) financing activities (62,887) 321,581
Increase (decrease) in cash, cash equivalents, and restricted cash (8,046) 46,432
Cash, cash equivalents, and restricted cash at beginning of period 118,177 59,144
Cash, cash equivalents, and restricted cash at end of period 110,131 105,576
Interest paid 33,284 21,088
Non-cash changes in deferred funding obligations (financing activity) 1,674 175,970
Non-cash changes in receivables and investments (investing activity) 0 (175,970)
Non-cash changes in residual assets (investing activity) $ (16,883) $ (11,061)